PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Illig, D.* ; Kotlarz, D.M.

Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD.

Front. Immunol. 13:1027289 (2022)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Inflammatory bowel disease (IBD) is a multifactorial disorder triggered by imbalances of the microbiome and immune dysregulations in genetically susceptible individuals. Several mouse and human studies have demonstrated that multimeric inflammasomes are critical regulators of host defense and gut homeostasis by modulating immune responses to pathogen- or damage-associated molecular patterns. In the context of IBD, excessive production of pro-inflammatory Interleukin-1β has been detected in patient-derived intestinal tissues and correlated with the disease severity or failure to respond to anti-tumor necrosis factor therapy. Correspondingly, genome-wide association studies have suggested that single nucleotide polymorphisms in inflammasome components might be associated with risk of IBD development. The relevance of inflammasomes in controlling human intestinal homeostasis has been further exemplified by the discovery of very early onset IBD (VEO-IBD) patients with monogenic defects affecting different molecules in the complex regulatory network of inflammasome activity. This review provides an overview of known causative monogenic entities of VEO-IBD associated with altered inflammasome activity. A better understanding of the molecular mechanisms controlling inflammasomes in monogenic VEO-IBD may open novel therapeutic avenues for rare and common inflammatory diseases.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
8.786
0.000
4
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Veo-ibd ; Genetics ; Immunodeficiency ; Inflammasome ; Inflammation ; Pediatrics; Nf-kappa-b; Familial Mediterranean Fever; Wiskott-aldrich-syndrome; Encoding Mevalonate Kinase; Immune Effector Mechanism; Gamma-inducing Factor; Regulatory T-cells; Nlrp3 Inflammasome; Bowel-disease; Crohns-disease
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 1664-3224
e-ISSN 1664-3224
Journal Frontiers in Immunology
Quellenangaben Volume: 13, Issue: , Pages: , Article Number: 1027289 Supplement: ,
Publisher Frontiers
Publishing Place Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Reviewing status Peer reviewed
Institute(s) Institute of Translational Genomics (ITG)
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Genetics and Epidemiology
PSP Element(s) G-506700-001
Grants Care-for-Rare Foundation
Else Kroener-Fresenius-Stiftung, Helmholtz Association/Helmholtz Munich (Helmholtz Young Investigator Group)
Leona M. and Harry B. Helmsley Charitable Trust, DFG
DOI 10.3389/fimmu.2022.1027289
WOS ID 000897815600001
WOS ID WOS:000897815600001
Scopus ID 85143912360
PubMed ID 36524121
Erfassungsdatum 2022-12-20
[➜Report correction]